Phase II Study of Compliance and Morbidity with 4 Cycles of Taxotere Followed by 4 of Doxorubicin-Cyclophosphamide for Adjuvant Treatment of Operable Breast Cancer Patients
-
- Asian Pacific Journal of Cancer Prevention
- /
- v.17 no.8
- /
- pp.4031-4035
- /
- 2016